Table 1.

List of outcome measures

	Group 1	Group 2	Group 3	Group 4
Outcome group	Glycaemic control evaluation outcomes	Macrovascular complications preventive measures outcomes	Microvascular complications preventive measures outcomes	Economic evaluation outcomes
Main outcome	Proportion of patients who were prescribed 3 measurements of glycosilated haemoglobin with at least two months' interval	Proportion of patients who were prescribed all macrovascular complications assessment tests (1)	Proportion of patients who were prescribed all microvascular complications assessment tests (2)	Marginal cost per each glycosilated haemoglobin measurement

⁽¹⁾ECG+lipid assessment (totalcholesterol + HDL cholesterol + triglycerides). ⁽²⁾ Ophtalmologic visit + funduscopy + urine albumin + serum creatinine